Unlocking the brain’s decision-making secrets for future insights

Researchers at Washington University School of Medicine in St. Louis have found important clues to how people make choices involving obtaining information about the future.

EMA approves Mitochon’s neurogenerative disease study – Pharmaceutical Technology

Share this article Mitochon’s small molecule candidate MP101 modulates mitochondrial function to treat neurogenerative diseases. Credit: Solskin via Getty Images. The European Medicines Agency (EMA)

January 10, 2024

WHO pandemic threat director: Here’s what needs to happen to combat mpox

There is a pervasive myth that the Democratic Republic of the Congo and other countries in Africa affected by the current mpox outbreak lack capacity

September 17, 2024

The health care issues we’re watching in tonight’s VP debate

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.